Sex-Specific Regulation of Inflammation and Metabolic Syndrome in Obesity.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsTer Horst, Rob
van den Munckhof, Inge C L
Smeekens, Sanne P
Galesloot, Tessel E
de Graaf, Jacqueline
Xavier, Ramnik J
Joosten, Leo A B
Rutten, Joost H W
Netea, Mihai G
Riksen, Niels P
MetadataShow full item record
AbstractMetabolic dysregulation and inflammation are important consequences of obesity and impact susceptibility to cardiovascular disease. Anti-inflammatory therapy in cardiovascular disease is being developed under the assumption that inflammatory pathways are identical in women and men, but it is not known if this is indeed the case. In this study, we assessed the sex-specific relation between inflammation and metabolic dysregulation in obesity. Approach and Results: Three hundred two individuals were included, half with a BMI 27 to 30 kg/m2 and half with a BMI>30 kg/m2, 45% were women. The presence of metabolic syndrome was assessed according to the National Cholesterol Education Program-ATPIII criteria, and inflammation was studied using circulating markers of inflammation, cell counts, and ex vivo cytokine production capacity of isolated immune cells. Additionally, lipidomic and metabolomic data were gathered, and subcutaneous fat biopsies were histologically assessed. Metabolic syndrome is associated with an increased inflammatory profile that profoundly differs between women and men: women with metabolic syndrome show a lower concentration of the anti-inflammatory adiponectin, whereas men show increased levels of several pro-inflammatory markers such as IL (interleukin)-6 and leptin. Adipose tissue inflammation showed similar sex-specific associations with these markers. Peripheral blood mononuclear cells isolated from men, but not women, with metabolic syndrome display enhanced cytokine production capacity.
CitationArterioscler Thromb Vasc Biol. 2020;40(7):1787-1800. doi:10.1161/ATVBAHA.120.314508.
AffiliationCiiM, Zentrum für individualisierte Infektionsmedizin, Feodor-Lynen-Str.7, 30625 Hannover.
PublisherLippincott, Williams & Wilkins
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- In Vivo and Ex Vivo Inflammatory Markers of Common Metabolic Phenotypes in Humans.
- Authors: Mærkedahl RB, Frøkiær H, Stenbæk MG, Nielsen CB, Lind MV, Lundtoft C, Bohr MB, Ibrügger S, Metzdorff SB, Vestergaard H, Pedersen O, Lauritzen L
- Issue date: 2018 Feb
- Leptin, adiponectin, and high-sensitivity C-reactive protein in relation to the metabolic syndrome in urban South African blacks with and without coronary artery disease.
- Authors: Ntyintyane L, Panz V, Raal FJ, Gill G
- Issue date: 2009 Jun
- Body fat distribution and inflammation among obese older adults with and without metabolic syndrome.
- Authors: Koster A, Stenholm S, Alley DE, Kim LJ, Simonsick EM, Kanaya AM, Visser M, Houston DK, Nicklas BJ, Tylavsky FA, Satterfield S, Goodpaster BH, Ferrucci L, Harris TB, Health ABC Study
- Issue date: 2010 Dec
- Metabolic syndrome, adiponectin and proinflammatory status in patients with type 1 diabetes mellitus.
- Authors: Timar R, Timar B, Degeratu D, Serafinceanu C, Oancea C
- Issue date: 2014 Oct
- Inflammation in metabolically healthy and metabolically abnormal adolescents: The HELENA study.
- Authors: González-Gil EM, Cadenas-Sanchez C, Santabárbara J, Bueno-Lozano G, Iglesia I, González-Gross M, Molnar D, Gottrand F, De Henauw S, Kafatos A, Widhalm K, Manios Y, Siani A, Amaro-Gahete F, Rupérez AI, Cañada D, Censi L, Kersting M, Dallongeville J, Marcos A, Ortega FB, Moreno LA, HELENA study group
- Issue date: 2018 Jan